Effect of auricular acupuncture on oxygen consumption of boxing athletes

Boxing is an official sport at the 2008 Beijing Olympic Games and the fast development of world-class high strength training and sport science has made a significant impact on scientific training. Boxing needs high cardio-respiratory function, speed, muscle strength, and anaerobic and intensive physical demands including weight control covering the grading of athlete＇s body weight and balancing physical ability and health. Sport training is important even for talented athletes. Weight cycling is a term used to describe rapid weight loss following self food limitation and/or dehydration. Both gradual （seasonal） reduction cycles are used and rapid （weekly） weight by athletes,     

Effect of auricular acupuncture on oxygen consumption of boxing athletes

Boxing is an official sport at the 2008 Beijing Olympic Games and the fast development of world-class high strength training and sport science has made a significant impact on scientific training. Boxing needs high cardio-respiratory function, speed, muscle strength, and anaerobic and intensive physical demands including weight control covering the grading of athlete's.     

Mutational analysis of hypoxia‐related genes HIF1α and CUL2 in common human cancers

Park SW, Chung NG, Hur SY, Kim HS, Yoo NJ, Lee SH. Mutational analysis of hypoxia‐related genes HIF1α and CUL2 in common human cancers. APMIS 2009; 117: 880–5. Hypoxia is a general feature of solid cancer tissues. Hypoxia upregulates hypoxia‐inducible factor 1α (HIF1α) that transactivates downstream genes and contributes to cancer pathogenesis. HIF1α is upregulated not only by hypoxia but also by genetic alterations in HIF1α‐related genes, including VHL. Cullin 2 (CUL2) interacts with the trimeric VHL‐elongin B‐elongin C complex and plays an essential role in the ubiquitinated degradation of HIF1α. The aim of this study was to explore whether HIF1α and CUL2 genes are somatically mutated, and contribute to HIF1α activation in common human cancers. For this, we have analyzed the coding region of oxygen‐dependent degradation domain of HIF1α in 47 colon, 47 gastric, 47 breast, 47 lung, and 47 hepatocellular carcinomas, and 47 acute leukemias by a single‐strand conformation polymorphism assay. In addition, we analyzed mononucleotide repeat sequences (A8) in CUL2 in 55 colorectal and 45 gastric carcinomas with microsatellite instability (MSI). We found one HIF1α mutation (p.Ala593Pro) in the hepatocellular carcinomas (1/47; 2.1%), but none in other cancers. We found two CUL2 frameshift mutations in colon cancers (p.Asn292MetfsX20), which were exclusively detected in high MSI cancers (4.9%; 2/41). Our data indicate that somatic mutation of HIF1α is rare in common cancers, and somatic mutation of CUL2 occurs in a fraction of colorectal cancers (colorectal cancers with high MSI). The data suggest that neither HIF1α nor CUL2 mutation may play a central role in HIF1α activation in gastric, colorectal, breast, lung and hepatocellular carcinomas, and acute leukemias.     

Efficacy and complications of adalimumab treatment for medically-refractory Crohn's disease: analysis of nationwide experience in Scotland (2004–2008)

Background  Adalimumab is a second generation humanized anti-tumour necrosis factor (TNF) monoclonal antibody with established efficacy in Crohn's disease (CD).
Aims  To evaluate the efficacy and safety of adalimumab on a nationwide clinical setting.
Methods  We used the Scottish Society of Gastroenterology network to identify and follow up the clinical outcomes of patients with CD treated with adalimumab over a 4-year period (2004–2008).
Results  A total of 98 patients received adalimumab - 100.5 patient follow-up years were recorded (64.3% females; median age at diagnosis of 20.7 years; 88.8% treated with 80/40 mg induction regimen. Eighty eight (89.8%) had previous infliximab with 29 (32.9%) primary nonresponders; 32 (32.6%) were corticosteroid-dependent; 47 (47.9%) were intolerant/resistant to most immunosuppressive therapies (two or more). In all, 60% of patients were in clinical remission at 1-year follow-up, with 30% and 55% requiring dose escalation to weekly therapy at 1-and 2-year follow-up respectively. Overall, 29 (29.6%) patients developed complications with eight nonfatal serious (8.2%) adverse events and 2 (2.0%) case fatalities (sepsis following perforation and disseminated colorectal cancer, respectively).
Conclusions  Adalimumab is efficacious in severe and refractory CD in the clinical setting, although there remain significant therapy- and disease-related risks of serious complications.     

穿龙薯芋中两种水难溶性甾体皂甙的结构研究

中国科学院成都生物研究所等单位用四川汶川,茂汶产的穿龙薯芋根茎为原料,研制成治疗冠心病,抗动脉粥样硬化的药——“穿龙冠心宁”,经鉴定有一定疗效。我们从“穿龙冠心宁”的原料穿龙薯芋(Dioscorea nipponica Makino)中提取出两种水难溶组分:其一为无色针状晶体,熔点275.5～280℃(分解),[α]_D~(21)-118°(C=0.39吡啶),易溶于吡啶,氯仿一甲醇(3:1)混合液和热甲醇,稍溶于氯仿,微溶于乙醇,不溶于水,命名为Da;其二亦为无色针状晶体,熔点293～295℃(分解),[α]_D~(21)-81°(C=0.31吡啶),易溶于吡啶,热正丁醇—乙醇—水(3:1:1)混合液,可溶于甲醇,微溶于乙醇,不溶于水,命名为Db。Da、Db与水溶性成分共存时,则具有较大的水溶性。     

Outcome of severely injured trauma patients at a designated trauma centre in the Hong Kong Special Administrative Region

Background The Hong Kong Special Administrative Region （HKSAR） of the People＇s Republic of China （PRC） has seen significant changes in its trauma service over the last ten years including the implementation of a regional trauma system. The author＇s institution is one of the five trauma centres designated in 2003. This article reports our initial clinical experience. Methods A prospective single-centre trauma registry from January 2004 to December 2008 was reviewed. The primary clinical outcome measure was hospital mortality. The Trauma and Injury Severity Score （TRISS） methodology was used for bench-marking with the North America Major Trauma Outcome Study （MTOS） database. Results There were 1451 patients. The majority （83.9%） suffered from blunt injury. The overall mortality rate was 7.8%. Severe injury, defined as the Injury Severity Score 〉15, occurred in 22.5% of patients, and was associated with a mortality rate of 31.6%. A trend of progressive improvement was noted. The M-statistic was 0.99, indicating comparable case-mix with the MTOS. The Z- and W-statistics of each individual year revealed fewer, but not significantly so, number of survivors than expected. Conclusions Trauma centre designation was feasible in the HKSAR and was associated with a gradual improvement in patient care. Trauma system implementation may be considered in regions equipped with the necessary socio-economic and organizational set-up.     

Angiographic and Clinical Outcomes of Everolimus‐Eluting Stent in the Treatment of Extra Long Stenoses (AEETES)

Objectives

The purpose of this study was to examine the angiographic and clinical results of stent full metal jacket in treating long lesions using everolimus‐eluting stents (EES).

Background

Data are lacking regarding the use of EES for this lesion subgroup.

Methods

From 2007 to 2011, 77 symptomatic patients who had severe coronary stenoses necessitating implantation of stents with total length longer than 60 mm were treated with overlapping EES.

Results

The mean age of patient was 61 ± 11 years with male predominance (66%). Diabetes mellitus was seen in 35 (45.5%) patients. Majority of patients had class III angina with normal heart function. On average, 3.1 stents were implanted per lesion; the mean stent size and length were 2.70 ± 0.28 mm and 82 ± 16 mm. Restudy angiography was performed on 71 patients (72 lesions) at 8.9 ± 2.5 months. Angiographic restenosis was seen in 9 (12.5%) lesions; the lesion length and late loss were 67 ± 15 mm and 0.4 ± 0.6 mm, respectively. The use of intravascular ultrasound has been found to be a predictor of less restenosis (P = 0.02; HR: 0.02; CI: 0.01–0.59). The in‐hospital and 1 year major adverse cardiac event rates were 7.8% and 13%. The annual cardiac death rates were 2.6%, 3.4%, and 5.3% in the first 3 years.

Conclusions

The use of EES full metal jacket for long lesions is only associated with good short‐term clinical and angiographic outcomes. Long‐term follow‐up has revealed a high cardiac death rate which may necessitate prolongation of dual antiplatelet therapy. (J Interven Cardiol 2013;26:22–28)

     

胰岛素瘤相关蛋白-2高表达对胰岛细胞增殖的影响

目的:探讨1型糖尿病自身抗原胰岛素瘤相关蛋白-2(IA鄄2)高表达对胰岛细胞系RIN5F细胞增殖、生长周期和细胞凋亡的影响。方法:利用分子克隆技术构建IA鄄2真核表达载体,转染RIN5F细胞后筛选稳定高表达IA鄄2的细胞系,采用3鄄(4,5鄄二甲基)鄄5鄄(3鄄羧甲基苯环)鄄2鄄(4鄄硫基苯)鄄2H鄄四唑盐复合物(MTS)检测法确定细胞增殖速率,运用流式细胞术检测细胞生长周期和细胞凋亡水平。结果:IA鄄2高表达细胞增殖速率显著低于载体对照组细胞(P<0.05)。IA鄄2高表达细胞的细胞凋亡数显著高于载体对照组细胞(P<0.01)。IA鄄2高表达细胞中位于S期的细胞比率显著增加,而G2/M期的细胞比率减少(P<0.05)。结论:IA鄄2在胰岛细胞内高表达可抑制胰岛细胞的增殖,促进细胞凋亡,在G2鄄M期细胞生长阻滞。     

18F-FDG及11C-乙酸盐PET/CT诊断原发及转移性肝细胞癌:一项前瞻性研究的价值与不足分析

肝细胞癌是亚洲地区发病率最高的肿瘤之一,因此有众多的研究涉及肝细胞癌.然而,在研究中所用统计学方法和技术等不当易得出不正确的概念和结论.作者就已发表在美国<核医学杂志>上的<18F-FDG及11C-乙酸盐PET/CT诊断原发及转移性肝细胞癌的前瞻性研究>一文提出了一些不同观点,希望这方面的研究者能掌握正确的统计学方法、诊断标准及样本人选标准.